We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery

To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.

At Miltenyi Biotec, we have developed reliable tools and methods for analyzing and enriching rare populations of SARS-CoV-2–specific B cells. Learn how our products and protocols facilitate COVID-19 research and support the discovery and development of therapeutic antibodies against SARS-CoV-2 and other diseases in this webinar.

Attend this webinar to:

  • Understand how antigen-specific lymphocytes work together against SARS-CoV-2
  • Learn about tools and protocols for monitoring and researching SARS-CoV-2–specific B cells
  • Explore the generation of monoclonal antibodies from antigen-specific B cells
Dr Susanne Bethke
Dr Susanne Bethke
Global Product Manager for B Cell Immunology, Miltenyi Biotec